The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Dai
Chia-Yen
CY
Department of Internal Medicine, Hepatobiliary Division, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang
Wan-Long
WL
Chang
Wen-Yu
WY
Chen
Shinn-Cherng
SC
Lee
Li-Po
LP
Lin
Zu-Yau
ZY
Hou
Nei-Jen
NJ
Hsieh
Ming-Yuh
MY
Wang
Liang-Yen
LY
Yu
Ming-Lung
ML
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001483:Base Sequence; D018136:Circoviridae / Q000235:genetics / Q000302:isolation & purification; D018173:Circoviridae Infections / Q000150:complications* / Q000188:drug therapy; D004279:DNA, Viral / Q000097:blood / Q000235:genetics; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*; D013624:Taiwan; D014766:Viremia / Q000821:virology
D000998:Antiviral Agents; D004279:DNA, Viral; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin